ARTICLE | Clinical News
Bafetinib: Pilot trial started
November 22, 2010 8:00 AM UTC
CytRx began an open-label, U.S. pilot trial in 6-8 patients with recurrent primary brain cancer or recurrent brain metastases to evaluate twice-daily oral bafetinib following intracerebral microdialys...